McKesson Corporation (NYSE:MCK) Given Consensus Rating of "Moderate Buy" by Analysts

Key Points

• Analysts have assigned McKesson a consensus rating of Moderate Buy from 16 firms (13 buy, 3 hold) with an average 12‑month target of $970.93 and top forecasts up to $1,107 (JPMorgan).
• McKesson beat quarterly estimates with EPS of $9.34 versus $9.19 and revenue of $106.16B (up 11.4% YoY), and issued FY2026 EPS guidance of $38.80–$39.20.
• Insiders have sold about 3,592 shares worth ~$3.52M (insiders now own 0.08%) while institutional investors hold roughly 85.07% of the stock; the company pays a modest annualized dividend of $3.28 (yield ~0.4%).

Shares of McKesson Corporation (NYSE:MCK - Get Free Report) have been assigned a consensus rating of "Moderate Buy" from the sixteen ratings firms that are currently covering the stock, MarketBeat.com reports. Three equities research analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company. The average 1 year target price among brokers that have issued ratings on the stock in the last year is $970.9333.

Several analysts have recently weighed in on MCK shares. Wall Street Zen downgraded shares of McKesson from a "buy" rating to a "hold" rating in a report on Saturday, April 11th. Wells Fargo & Company increased their price target on shares of McKesson from $914.00 to $925.00 and gave the company an "equal weight" rating in a research report on Thursday, February 5th. Raymond James Financial set a $970.00 price target on shares of McKesson in a report on Thursday, March 5th. JPMorgan Chase & Co. upped their price objective on shares of McKesson from $983.00 to $1,107.00 and gave the company an "overweight" rating in a research note on Tuesday, February 10th. Finally, TD Cowen increased their target price on shares of McKesson from $1,000.00 to $1,012.00 and gave the stock a "buy" rating in a research report on Thursday, February 5th.

Insider Buying and Selling

In related news, Director Maria Martinez sold 349 shares of the business's stock in a transaction that occurred on Thursday, February 19th. The stock was sold at an average price of $939.87, for a total transaction of $328,014.63. Following the completion of the transaction, the director owned 301 shares in the company, valued at $282,900.87. The trade was a 53.69% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CAO Napoleon B. Rutledge, Jr. sold 328 shares of the business's stock in a transaction that occurred on Friday, February 6th. The stock was sold at an average price of $955.00, for a total value of $313,240.00. The disclosure for this sale is available in the SEC filing. In the last ninety days, insiders have sold 3,592 shares of company stock valued at $3,518,555. 0.08% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently made changes to their positions in the company. University of Texas Texas AM Investment Management Co. acquired a new position in shares of McKesson in the fourth quarter worth $25,000. Swiss RE Ltd. acquired a new stake in shares of McKesson in the fourth quarter worth $26,000. GGM Financials LLC bought a new position in shares of McKesson during the 3rd quarter worth about $25,000. State of Wyoming bought a new position in McKesson during the second quarter valued at about $29,000. Finally, Hopwood Financial Services Inc. bought a new stake in shares of McKesson during the third quarter valued at approximately $31,000. 85.07% of the stock is currently owned by institutional investors and hedge funds.

McKesson Stock Down 0.1%

Shares of MCK stock opened at $862.09 on Thursday. The stock's 50-day moving average price is $917.65 and its 200 day moving average price is $853.54. The stock has a market capitalization of $105.60 billion, a PE ratio of 24.79, a price-to-earnings-growth ratio of 1.24 and a beta of 0.42. McKesson has a 52-week low of $637.00 and a 52-week high of $999.00.

McKesson (NYSE:MCK - Get Free Report) last posted its quarterly earnings data on Wednesday, February 4th. The company reported $9.34 earnings per share for the quarter, topping analysts' consensus estimates of $9.19 by $0.15. The company had revenue of $106.16 billion during the quarter, compared to analysts' expectations of $105.98 billion. McKesson had a negative return on equity of 338.97% and a net margin of 1.09%.The firm's revenue for the quarter was up 11.4% on a year-over-year basis. During the same period last year, the firm earned $8.03 EPS. McKesson has set its FY 2026 guidance at 38.800-39.200 EPS. Analysts expect that McKesson will post 32.77 earnings per share for the current fiscal year.

McKesson Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, April 1st. Investors of record on Monday, March 2nd were paid a dividend of $0.82 per share. The ex-dividend date was Monday, March 2nd. This represents a $3.28 annualized dividend and a yield of 0.4%. McKesson's dividend payout ratio (DPR) is 9.43%.

About McKesson

McKesson Corporation NYSE: MCK is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company's core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.